title: Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell support.
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Niklas
authors.initials: N
authors.lastname: Gebauer
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Harald
authors.initials: H
authors.lastname: Biersack
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Ann-Cathrin
authors.initials: AC
authors.lastname: Czerwinska
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Janina
authors.initials: J
authors.lastname: Schemme
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Tim Tristan
authors.initials: TT
authors.lastname: Hardel
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Veronica
authors.initials: V
authors.lastname: Bernard
authors.affiliation: c Department of Radiation Oncology , University Hospital of Schleswig-Holstein , Luebeck , Germany.
authors.forename: Dirk
authors.initials: D
authors.lastname: Rades
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Hendrik
authors.initials: H
authors.lastname: Lehnert
authors.affiliation: a Department of Internal Medicine I , University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Kim Barbara
authors.initials: KB
authors.lastname: Luley
authors.affiliation: b Department of Pathology , Reference Centre for Lymph Node Pathology and Hematopathology, University Hospital of Schleswig-Holstein , Luebeck , Germany ;
authors.forename: Christoph
authors.initials: C
authors.lastname: Thorns
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053208:Kaplan-Meier Estimate; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000235:genetics* / Q000401:mortality* / Q000628:therapy; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D016159:Tumor Suppressor Protein p53; D051736:Proto-Oncogene Proteins c-mdm2; D016283:Proto-Oncogene Proteins p21(ras); D008558:Melphalan